Image source: ACADIA Pharmaceuticals.
It’s an interesting time to be an investor in ACADIA Pharmaceuticals (NASDAQ: ACAD). The company is in the middle of transforming itself from a clinical-stage enterprise into a commercial one, which can be a tricky transition to execute successfully.